Archives for January 2018

Compounding pharmacy increasingly popular during flu season

 

Compounding pharmacy has become increasingly popular across Central Florida since the uptick in flu cases.

Eyewitness News reported last week that there is a shortage of the generic version of Tamiflu and the price of brand-name of Tamiflu has skyrocketed.

FDA Releases Compounding Priorities Plan

The U.S. Food and Drug Administration on Jan. 24 issued its 2018 Compounding Policy Priorities Plan, which outlines how the agency will implement key aspects of the Drug Quality and Security Act and other provisions of the law relevant to compounders.

Top Organizations Urge a Concerted Effort To Improve Safety in Hospital Compounding

Five years after the New England Compounding Center (NECC) tragedy that brought to light safety problems stemming from the compounding of pharmaceuticals and other therapies, a white paper was released today reflecting the recommendations of major stakeholders for additional steps needed to improve patient safety relative to compounded medicines.  The paper was the outcropping of a milestone dialogue where top pharmacy, healthcare provider, hospital and patient organizations assessed progress made since the 2012 NECC tragedy and the subsequent enactment of the Drug Quality and Security Act by Congress.

Hospitals face shortage of IV bags amid flu outbreak

 

TREASURE VALLEY — Hospitals across the nation continue to battle a shortage of IV solution bags – now, amid an early and aggressive flu season.

CLEAN BENCHES

 

Providing Additional Clean Room Technology

The laminar flow clean bench is a work bench or similar enclosure which has its own filtered air supply. The clean bench was developed as an adjunct to clean room technology (the need to protect the work from contamination). In recent years, the use of the clean bench, laminar flow cabinet or laminar flow hood has spread from research and manufacturing to other fields such as aerospace, bioscience, pharmaceutical production and food processing.

FDA Unveils Guidance To Smooth Generic-Drug Path

Law360, New York (January 3, 2018, 5:48 PM EST) — The U.S. Food and Drug Administration on Wednesday unveiled draft guidance for the pharmaceutical industry and an internal manual of policies and procedures that it says will streamline the approval process for generic drugs, in part by reducing the number of times an application must be reviewed.